LRVHealth pursues venture-stage investments in technology-based businesses in healthcare, including software, SaaS, digital health, technology-enabled services, clinical services, diagnostic tools, and medical devices, across Seed through Series C stages.
Operator of a genomic medicine delivery company intended to bridge the gap between genome technology and current medical practice. The company connects individuals and health care providers to genetic experts, providing a genetic assessment to individuals regarding the benefits of testing and creating a personalized clinical action plan, enabling patients to make informed treatment decisions at low costs and medical practitioners to accelerate disease diagnosis.